DLGAP5 and hepatocellular carcinoma: To confirm the findings, we analyzed the expression of DLGAP5 in some HCC cell lines including YY8103, BEL7404, PLC/PRF/5, QGY7701 and Huh7 treated by 5'azacytidine (DAC) compared with no drug treatment.